LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

MACKENZIE FINANCIAL CORP's Holding History (CIK: 0000919859)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 11,205 Value ($000) $6 Avg Close — Range —
Q4 2024
Shares 11,205 Value ($000) $7 Avg Close — Range —
Q3 2024
Shares 11,205 Value ($000) $15 Avg Close — Range —
Q2 2024
Shares 11,205 Value ($000) $16 Avg Close — Range —
Q1 2024
Shares 11,205 Value ($000) $25 Avg Close — Range —
Q4 2023
Shares 11,205 Value ($000) $22 Avg Close — Range —
Q3 2023
Shares 11,205 Value ($000) $16 Avg Close — Range —
Q2 2023
Shares 11,205 Value ($000) $35 Avg Close — Range —
Q1 2023
Shares 11,205 Value ($000) $26 Avg Close — Range —
Q4 2022
Shares 11,205 Value ($000) $39 Avg Close — Range —
Q3 2022
Shares 11,205 Value ($000) $82 Avg Close — Range —
Q2 2022
Shares 11,798 Value ($000) $77 Avg Close — Range —